IGN — Inno-Gene SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN9.69m
- PLN5.05m
- PLN1.13m
Annual cashflow statement for Inno-Gene SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | PAS | PAS | PAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.165 | 1.57 | 6.14 | 0.33 | -1.46 |
| Depreciation | |||||
| Non-Cash Items | -0.006 | -0.658 | 0.572 | 0.109 | 0.018 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.296 | -2.83 | -0.765 | -0.919 | -1.11 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.997 | -0.975 | 6.98 | 0.088 | -2.48 |
| Capital Expenditures | -0.961 | -0.024 | -0.082 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.22 | -0.598 | -2.31 | -2.77 | 1.76 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.18 | -0.622 | -2.39 | -2.77 | 1.76 |
| Financing Cash Flow Items | -0.001 | -0.106 | 0.031 | 0.255 | 0.683 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.179 | 1.85 | -0.952 | -1.08 | 0.855 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.005 | 0.253 | 3.64 | -3.76 | 0.133 |